Related Experiment Video

Updated: Apr 23, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease

Tyler Calway1, Gene H Kim2

  • 1Institute for Cardiovascular Research, University of Chicago, Chicago, IL, USA.

Journal of Cardiovascular Pharmacology and Therapeutics
|September 28, 2014
PubMed

Insights

MicroRNAs (miRNAs) show promise for treating cardiovascular diseases by regulating gene expression. Advances in oligonucleotide delivery enable targeted miRNA therapies for heart conditions in mammalian models.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality and significant healthcare costs.
  • Understanding the molecular mechanisms of CVDs is crucial for developing effective treatments.
  • MicroRNAs (miRNAs) are key regulators of biological pathways and stress responses relevant to CVDs.

Purpose of the Study:

  • To review the role of miRNAs in cardiovascular diseases.
  • To discuss recent advances in using miRNAs as therapeutic targets for CVDs.
  • To explore in vivo applications of miRNA-based therapies in mammalian models.

Main Methods:

  • Literature review of studies on miRNAs and cardiovascular diseases.
  • Analysis of current oligonucleotide delivery methods for miRNA therapeutics.
  • Examination of in vivo studies in mammalian models.

Main Results:

  • miRNA signatures can identify therapeutic targets for CVDs.
  • miRNA adjustments can alter gene and protein expression to treat cardiac pathologies.
  • Oligonucleotide delivery systems offer targeted approaches for single or multiple miRNAs and specific tissues.

Conclusions:

  • miRNAs represent a promising therapeutic avenue for cardiovascular diseases.
  • In vivo applications of miRNA-based strategies are advancing rapidly.
  • Targeted delivery methods enhance the potential of miRNA therapies for CVDs.

Keywords:
cardiovascular diseasemicroRNAtherapeutics

More Related Videos

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

7.5K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
MicroRNAs01:22

MicroRNAs

9.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K